This has been on my radar since the RTO into OMT which I held as...

This has been on my radar since the RTO into OMT which I held as a shell. Sold the shell rtade but kept this one on watch list.
Upon reviewing the revenue it occured to me this was super cheap for its MC and I bought on recent retrace.
Thing is, its not fancy... its certainly not high risk all or nothing bio dependant on trial results. And its not pie in the sky or untested tech. It is absolute bread and butter for current medical practice both general and specialist, inpatient and outpatient. It makes a platform for storing and viewing Xrays and other radiology scans. Every doctor uses a PACS system to look at patient scans, and every radiology practice/hospital uses one to store scans it does and to view them. Indispensable.
IME has a large footprint, penetration and reputation in South America which is a massive market alone (without global expansion). Huge populations, and underdeveloped medical infrastructure so ripe markets for new deals like the one we saw today.
And the current ASX environment for bio's makes this a very strong stock IMO.